Discover the top pharmaceutical companies in India ranked by their market capitalization. These companies are industry leaders contributing significantly to healthcare innovation and the Indian economy.

Top Pharma Stocks in India by Market Capitalization

India leads in generic drug production, supplying 20% of global generics and 60% of vaccines. Government initiatives like PLI and PTUAS boost the sector's growth and innovation.

Pharma Industry Overview

Sun Pharma is India's largest pharmaceutical company, offering a diverse range of generic and branded medicines. Based in Mumbai, it serves over 100 markets globally. Data as of 11th January 2025. Source NSE

Sun Pharma | Market Cap: ₹4,28,522.75 Crore

Divis Laboratories specializes in active pharmaceutical ingredients (APIs) and intermediates. Headquartered in Hyderabad, it is a trusted name in the global pharma supply chain. Data as of 11th January 2025. Source NSE

Divis Labs | Market Cap: ₹1,53,075.82 Crore

Cipla, headquartered in Mumbai, is renowned for its respiratory and anti-infective medicines. It has a significant presence in both Indian and international markets. Data as of 11th January 2025. Source NSE

Cipla | Market Cap: ₹1,18,945.40 Crore

Mankind Pharma is a leader in India's domestic pharma market, known for over-the-counter products like Manforce Condoms and Prega News. It operates out of New Delhi. Data as of 11th January 2025. Source NSE

Mankind Pharma | Market Cap: ₹1,13,125.84 Crore

Dr. Reddy's Laboratories, based in Hyderabad, offers affordable and innovative medicines in over 25 countries. It is a key player in the global generic drug industry. Data as of 11th January 2025. Source NSE

Dr. Reddy's Labs | Market Cap: ₹1,13,281.40 Crore

Torrent Pharma, headquartered in Ahmedabad, focuses on therapeutic areas such as cardiovascular, central nervous system, and diabetes. It has a robust presence in domestic and global markets. Data as of 11th Jan. 2025. Source NSE

Torrent Pharma | Market Cap: ₹1,10,510.90 Crore

Lupin, headquartered in Mumbai, excels in manufacturing generics and branded formulations. It is known for its focus on cardiovascular, diabetes, and respiratory segments. Data as of 11th January 2025. Source NSE

Lupin | Market Cap: ₹1,00,097.86 Crore

Zydus Lifesciences, headquartered in Ahmedabad, is a leader in vaccines and biosimilars. Its popular products include Lipaglyn and ZyCoV-D, India's first COVID-19 DNA vaccine. Data as of 11th January 2025. Source NSE

Zydus Lifesciences | Market Cap: ₹1,01,025.89 Crore

India's pharmaceutical sector is a cornerstone of the global healthcare landscape. Companies like Sun Pharma, Cipla, and Divis Labs exemplify the industry's excellence, contributing significantly to both domestic and global markets.

Conclusion – Understanding Pharma Stocks

-->